Enliven Therapeutics ELVN Price / book

Price / book at other companies

Bristol-Myers SquibbBMY

5.3×-0.2×

PfizerPFE

1.8×+0.2×

Iovance Biotherapeutics, Inc.IOVA

2.5×+1.6×

Syndax PharmaceuticalsSNDX

49.5×+44.6×

CTO

Citius Oncology, Inc.CTOR

1.6×-0.3×

Cullinan Therapeutics, Inc.CGEM

1.5×+0.3×

FAQ

What is Enliven Therapeutics's price / book?

Enliven Therapeutics (ELVN) reported price / book of 5.2× in Q1 2026.

How has Enliven Therapeutics's price / book changed year-over-year?

Enliven Therapeutics's price / book increased by 54.6% year-over-year, from 3.3× to 5.2×.

What is the long-term trend for Enliven Therapeutics's price / book?

Over 3 years (2020 to 2025), Enliven Therapeutics's price / book has grown at a -24.3% compound annual growth rate (CAGR), from 4.6× to 2×.

What does price / book mean?

Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.